Dianthus Therapeutics, Inc. · NASDAQ:DNTH

BlackRock, Inc. reported a 6.40% stake in Dianthus Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Jul 28, 2026

BlackRock, Inc. reported a 6.40% stake in Dianthus Therapeutics, Inc., 3,504,166 shares, as a passive investor on Jun 30, 2026. Filed Jul 28, 2026 (Schedule 13G/A).

Stake
6.40%
Shares
3,504,166
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.6.40%3,504,166

Source

View original at SEC

Related